- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
Brand Name :
Diastat, Diastat AcuDial, Valium
Synonyms :
Class :
Anxiolytics; Benzodiazepines
Dosage forms & Strengths:
Adult:
Oral solution:
1 mg/ml
5 mg/ml
Schedule IV tablet:
2 mg
5 mg
10 mg
Injectable solution:
5 mg/ml
Rectal gel:
2.5 mg
10 mg
20 mg
2 - 10
mg
Orally
every 6 hrs
Tablet
alcohol withdrawal syndrome (AWS)
10
mg
Orally
every 8 hrs
Tablet
2 - 10
mg
Orally
every 8 hrs
Tablet
2 - 10
mg
Orally
every 8 hrs
Tablet
5 - 10
mg
Intramuscular (IM)
Every 10 minutes
Solution
2 - 10
mg
Orally
every 6 hrs
alcohol withdrawal syndrome (AWS)
Orally
every 8 hrs
2 - 10
mg
Orally
every 6 hrs
2 - 2.5
mg
Orally
every 12 hrs
12
hrs
Tablet
2 - 2.5
mg
Orally
every 12 hrs
The interaction may increase the risk of sedation, respiratory depression, and coma
The interaction may increase the risk of sedation, respiratory depression, and coma
The interaction may increase the risk of sedation, respiratory depression, and coma
lemborexant may enhance the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS Depressants
may have an increased CNS depressant effect when combined with buprenorphine
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with methotrimeprazine
may have an increased CNS depressive effect when combined with oxycodone
may have an increased CNS depressant effect when combined with flunitrazepam
may have an increased CNS depressant effect when combined with CNS depressants
calcium, magnesium, potassium and sodium oxybate
may have an increased CNS depressant effect when combined with oxybate salt products
suvorexant: they may increase the CNS depressant effect of CNS Depressants
Ropeginterferon Alfa-2b: they may increase the adverse effect of CNS Depressants
It may enhance the effect when combined with pharmacodynamic synergism
CYP3A strong enhancers of the small intestine may reduce the bioavailability of diazepam
may increase the CNS depressant effect
may increase the CNS depressant effect
CNS depressants increase the effect of CNS depression of thalidomide
CNS depressants increase the efficacy of cannabinoid products
CNS depressants increase the efficacy of cannabinoid products
may increase the CNS depressant effect of bromperidol
may have an increased CNS depressive effect when combined with flunarizine
it increases the effect of CNS depressants
may have an increased CNS depressant effect when combined with orphenadrine
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with paraldehyde
may increase the CNS depressant effect of flibanserin
